Target intelligence / Profile preview

Elastin microfibril interfacer 2 pseudogene

Molecular classification
Pseudogene, Processed pseudogene (Based on proximity and genomic context[3]), Other
01

Overview

Elastin microfibril interfacer 2 pseudogene (ENSG00000276632) is classified as a processed pseudogene—it is a noncoding genomic locus that resembles a functional gene but contains mutations that prevent translation into a protein[3][1]. Pseudogenes often arise through duplication or retrotransposition and lack the capability to encode a functional protein; they may retain intron-exon structure or have features such as polyA tracts, but generally do not produce biologically active proteins[1]. While some pseudogenes have emerged as regulators of gene expression—acting as sources of small interfering RNAs or as decoys for microRNAs—most remain biologically silent, and there is no published evidence that this particular pseudogene has a specific regulatory or disease function[1][5]. It is not considered a therapeutic target, and does not possess molecular features typical of receptors, enzymes, transporters, or other druggable protein classes. If you require information on a functional protein, receptor, or enzyme, consider searching for the parent gene or a true protein-coding locus rather than this pseudogene.

Other names
ENSG00000276632Elastin microfibril interfacer 2 pseudogene
02

Biological functions

Potential noncoding RNA regulator (as with other pseudogenes[1][5])Possible microRNA decoy or source of regulatory RNAs (suggested for some pseudogenes, but not specifically shown for this locus[1][5])Other
03

Disease associations

Other (Pseudogenes may play regulatory roles in cancer and other diseases, but there is no evidence for this specific pseudogene[1][5])

Beyond the preview

Go deeper on Elastin microfibril interfacer 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elastin microfibril interfacer 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call